Comment from Physicians Committee for Responsible Medicine (PCRM)

Summary: The Physicians Committee for Responsible Medicine (PCRM) supports the FDA's draft guidance on New Approach Methodologies (NAMs) in drug development. They advocate for revisions that emphasize flexible, fit-for-purpose validation strategies, prioritize human biological relevance, and move away from a heavy reliance on historical animal testing.